BioCentury
ARTICLE | Company News

SkyePharma, Medac deal

September 7, 1999 7:00 AM UTC

SKP will acquire Medac's nanoparticle drug delivery technology for an upfront payment of $2.5 million in cash, 3.1 million newly issued SKP shares valued at around £2.5 million ($4 million) and up to ...